Sourabh Dutta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sourabh Dutta has a total of 220 co-authors. Here are the top co-authors by number of shared publications:
- Venkataseshan Sundaram
Division of Neonatology, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India
11 shared publications Praveen Kumar
Division of Neonatology, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
10 shared publications- Shiv Sajan Saini
Division of Neonatology, Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
10 shared publications - Jogender Kumar
Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
8 shared publications Pallab Ray
Department of Medical Microbiology, PGIMER, Chandigarh, India
6 shared publications- Praveen Kumar
Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
6 shared publications
Latest Publications
- 22 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 32
Change in composition of blood after passing through circuit of automated device versus manual clinical method for neonatal exchange transfusions
We previously developed and published a novel device to automate double volume exchange transfusions (DVET) via the umbilical venous catheter (UVC) in neonates. Prior to initiating clinical trials, we aimed to demonstrate that alterations in blood composition after passage through our device’s circuit were not greater than those seen with the conventional manual method. We performed five ex vivo simulations of neonatal DVET using donor blood in standard blood bank bags and our automated device. Samples were obtained from the blood bag at baseline and from the distal end of the circuit after completion of 50% and 100% of the simulated DVET. These were analyzed for hematological, biochemical, and blood gas parameters, osmolality, and culture. For comparison, four manual DVETs were similarly performed, with corresponding sample collection and analyses. Deviations of laboratory parameters at the 50% and 100% time points that were > ± 25% from baseline were classified as major. The proportion of major deviations was compared between automated and manual DVETs. Automated DVETs demonstrated significantly fewer major deviations than manual DVETs in hematological parameters [15/156 (9.61%) vs. 28/124 (22.58%), p = 0.0048], biochemical parameters [0/120 (0%) vs. 32/88 (36.36%), p < 0.0001], and blood gas values [11/50 (22.0%) vs. 20/40 (50.0%), p = 0.011]. Notably, the blood used in automated DVETs was significantly older than that used in the manual group. Conclusion: Automated DVET using our novel device results in fewer compositional deviations from baseline compared to conventional manual DVET, supporting its potential clinical utility. What is Known: • Our research group previously developed and published a novel electromechanical device to perform double volume exchange transfusions (DVET) in neonates through the umbilical venous route. • Previous authors who had made automated devices did not analyze the composition of the blood exiting the device circuit (“post-circuit” composition), nor compared this to the conventional manual method of exchange transfusions. What is New: • In simulated DVETs performed with our device, there were significantly fewer changes in the post-circuit composition of the blood from baseline (hematological, biochemical, blood gas and osmolality values) compared to manual DVETs. • Among DVETs performed manually, 7 ml aliquots per cycle were associated with greater changes in the post-circuit composition of the blood compared to 10 ml aliquots per cycle.
- 22 December 2025
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (1) , 32
Change in composition of blood after passing through circuit of automated device versus manual clinical method for neonatal exchange transfusions
We previously developed and published a novel device to automate double volume exchange transfusions (DVET) via the umbilical venous catheter (UVC) in neonates. Prior to initiating clinical trials, we aimed to demonstrate that alterations in blood composition after passage through our device’s circuit were not greater than those seen with the conventional manual method. We performed five ex vivo simulations of neonatal DVET using donor blood in standard blood bank bags and our automated device. Samples were obtained from the blood bag at baseline and from the distal end of the circuit after completion of 50% and 100% of the simulated DVET. These were analyzed for hematological, biochemical, and blood gas parameters, osmolality, and culture. For comparison, four manual DVETs were similarly performed, with corresponding sample collection and analyses. Deviations of laboratory parameters at the 50% and 100% time points that were > ± 25% from baseline were classified as major. The proportion of major deviations was compared between automated and manual DVETs. Automated DVETs demonstrated significantly fewer major deviations than manual DVETs in hematological parameters [15/156 (9.61%) vs. 28/124 (22.58%), p = 0.0048], biochemical parameters [0/120 (0%) vs. 32/88 (36.36%), p < 0.0001], and blood gas values [11/50 (22.0%) vs. 20/40 (50.0%), p = 0.011]. Notably, the blood used in automated DVETs was significantly older than that used in the manual group. Conclusion: Automated DVET using our novel device results in fewer compositional deviations from baseline compared to conventional manual DVET, supporting its potential clinical utility. What is Known: • Our research group previously developed and published a novel electromechanical device to perform double volume exchange transfusions (DVET) in neonates through the umbilical venous route. • Previous authors who had made automated devices did not analyze the composition of the blood exiting the device circuit (“post-circuit” composition), nor compared this to the conventional manual method of exchange transfusions. What is New: • In simulated DVETs performed with our device, there were significantly fewer changes in the post-circuit composition of the blood from baseline (hematological, biochemical, blood gas and osmolality values) compared to manual DVETs. • Among DVETs performed manually, 7 ml aliquots per cycle were associated with greater changes in the post-circuit composition of the blood compared to 10 ml aliquots per cycle.
- 18 November 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (2) , 141-142
Intrapartum Antibiotic Exposure and Neonatal Sepsis
- 18 November 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 63 (2) , 141-142
Intrapartum Antibiotic Exposure and Neonatal Sepsis
- Open Access
- 15 October 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103543
Shorter or biomarker-guided antibiotic durations for common serious neonatal infections: a collection of non-inferiority meta-analyses
- 15 October 2025
- Published by Elsevier in eClinicalMedicine
- Vol. 89, 103543
Open AccessShorter or biomarker-guided antibiotic durations for common serious neonatal infections: a collection of non-inferiority meta-analyses
- 12 September 2025
- Published by SAGE Publications in Breastfeeding Medicine
- Vol. 20 (9) , 658-665
Prevalence, Concordance, and Risk Factors of Antibiotic Resistance Genes in Breast Milk and Neonatal Oral Cavity of Preterm Mother–Infant Pairs
Background: Mothers delivering preterm are very often exposed to antibiotics in the peripartum period. We hypothesize this may select bacteria bearing antibiotic resistance genes (ARGs) in the breast milk and be transmitted to the neonate’s mouth while feeding. This study aimed to determine the prevalence of ARGs coding for extended-spectrum beta-lactamases (ESBLs) (including AmpC beta-lactamases [ACBLs]) and carbapenemases in breast milk and neonatal oral swab samples of preterm mother–infant pairs, the concordance of ARGs between paired samples, and risk factors of ARGs coding for ESBLs and carbapenemases. Methods: Breast milk and oral swab samples were obtained aseptically from 100 preterm mother–infant pairs (gestation 28–34 weeks) by postpartum day 10. Multiplex PCR was used to detect 15 common ARGs in these samples. Potential risk factors of the presence of any ARG coding for ESBLs or carbapenemases in breast milk and oral swab samples were studied. Results: The commonest ARGs for ESBLs, ACBLs, and carbapenemases in breast milk were bla SHV (28%), bla CIT (33%), and bla IMP (49%), respectively; and oral swabs bla CTX-M1 (30%), bla CIT (58%), and bla IMP (24%), respectively. ARGs common to breast milk and oral swabs included bla CIT (13%), bla IMP (10%), bla CTX-M-1 (9%), and bla SHV (6%). Formula milk intake was associated with less oral carbapenemase ARGs. Conclusion: ARGs for ESBLs and carbapenemases are highly prevalent in preterm breast milk and oral swabs.
- 12 September 2025
- Published by SAGE Publications in Breastfeeding Medicine
- Vol. 20 (9) , 658-665
Prevalence, Concordance, and Risk Factors of Antibiotic Resistance Genes in Breast Milk and Neonatal Oral Cavity of Preterm Mother–Infant Pairs
Background: Mothers delivering preterm are very often exposed to antibiotics in the peripartum period. We hypothesize this may select bacteria bearing antibiotic resistance genes (ARGs) in the breast milk and be transmitted to the neonate’s mouth while feeding. This study aimed to determine the prevalence of ARGs coding for extended-spectrum beta-lactamases (ESBLs) (including AmpC beta-lactamases [ACBLs]) and carbapenemases in breast milk and neonatal oral swab samples of preterm mother–infant pairs, the concordance of ARGs between paired samples, and risk factors of ARGs coding for ESBLs and carbapenemases. Methods: Breast milk and oral swab samples were obtained aseptically from 100 preterm mother–infant pairs (gestation 28–34 weeks) by postpartum day 10. Multiplex PCR was used to detect 15 common ARGs in these samples. Potential risk factors of the presence of any ARG coding for ESBLs or carbapenemases in breast milk and oral swab samples were studied. Results: The commonest ARGs for ESBLs, ACBLs, and carbapenemases in breast milk were bla SHV (28%), bla CIT (33%), and bla IMP (49%), respectively; and oral swabs bla CTX-M1 (30%), bla CIT (58%), and bla IMP (24%), respectively. ARGs common to breast milk and oral swabs included bla CIT (13%), bla IMP (10%), bla CTX-M-1 (9%), and bla SHV (6%). Formula milk intake was associated with less oral carbapenemase ARGs. Conclusion: ARGs for ESBLs and carbapenemases are highly prevalent in preterm breast milk and oral swabs.
- 6 August 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (11) , 794-801
Effect of Intrapartum Antibiotic Exposure Time on Neonatal Sepsis: A Prospective Cohort Study
Objective To examine the association between the duration of intrapartum antibiotic exposure (IAE) and the risk of culture-negative early-onset neonatal sepsis (EONS) and any late-onset neonatal sepsis (LONS) in the first week. Methods Preterm neonates (≤ 34 weeks) were enrolled into: Group A (no IAE; n = 282), Group B (IAE < 24 h; n = 204) and Group C (IAE ≥ 24 h; n = 84). The risk factors for EONS and LONS were noted and all neonates were followed up for culture-negative EONS (primary outcome). Secondary outcomes included culture-positive EONS, culture-negative and culture-positive LONS, and multidrug-resistant sepsis. A univariable followed by multivariable analysis of risk factors to predict culture-negative EONS and LONS was performed. The cut-off (Youden’s index) of IAE associated with various outcomes was determined. Results From group A through C, gestation and birth weight declined, and the proportion at risk of EONS increased. Culture-negative EONS incidence increased (9.57% vs. 12.74% vs. 36.90%, respectively, Ptrends < 0.001), but its proportion among all EONS did not. Culture-positive LONS incidence declined (Ptrends = 0.038). The proportion of culture-negative LONS among all LONS increased (Ptrends = 0.024). Threshold values of 13.5 h and 4.5 h were associated with culture-negative EONS and culture-positive LONS in the first week, respectively. However, on adjusted analysis, IAE duration had no association with culture-negative EONS or LONS in the first week. Conclusions Duration of IAE is not independently associated with increased incidence of culture-negative EONS or any LONS.
- 6 August 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (11) , 794-801
Effect of Intrapartum Antibiotic Exposure Time on Neonatal Sepsis: A Prospective Cohort Study
Objective To examine the association between the duration of intrapartum antibiotic exposure (IAE) and the risk of culture-negative early-onset neonatal sepsis (EONS) and any late-onset neonatal sepsis (LONS) in the first week. Methods Preterm neonates (≤ 34 weeks) were enrolled into: Group A (no IAE; n = 282), Group B (IAE < 24 h; n = 204) and Group C (IAE ≥ 24 h; n = 84). The risk factors for EONS and LONS were noted and all neonates were followed up for culture-negative EONS (primary outcome). Secondary outcomes included culture-positive EONS, culture-negative and culture-positive LONS, and multidrug-resistant sepsis. A univariable followed by multivariable analysis of risk factors to predict culture-negative EONS and LONS was performed. The cut-off (Youden’s index) of IAE associated with various outcomes was determined. Results From group A through C, gestation and birth weight declined, and the proportion at risk of EONS increased. Culture-negative EONS incidence increased (9.57% vs. 12.74% vs. 36.90%, respectively, Ptrends < 0.001), but its proportion among all EONS did not. Culture-positive LONS incidence declined (Ptrends = 0.038). The proportion of culture-negative LONS among all LONS increased (Ptrends = 0.024). Threshold values of 13.5 h and 4.5 h were associated with culture-negative EONS and culture-positive LONS in the first week, respectively. However, on adjusted analysis, IAE duration had no association with culture-negative EONS or LONS in the first week. Conclusions Duration of IAE is not independently associated with increased incidence of culture-negative EONS or any LONS.
- 25 April 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Seven-day versus 14-day antibiotic course for culture-proven neonatal sepsis: a multicentre randomised non-inferiority trial in a low and middle-income country
Objective: Definitive guidance regarding the duration of antibiotics for neonatal sepsis is lacking. We hypothesised that a 7-day antibiotic course is non-inferior to a 14-day course for treating culture-proven sepsis. Design: Randomised, controlled, non-inferiority trial with masked outcome assessment in eight centres in a low and middle-income country. Patients: Neonates with a birth weight (BW) ≥1000 g and blood culture-proven sepsis were randomised on day 7 of sensitive antibiotic therapy provided sepsis had clinically remitted. Exclusions: Staphylococcus aureus or fungal sepsis, and infections requiring prolonged antibiotics. We planned to enrol 350 per group, assuming 10% rate of primary outcome, +7% non-inferiority margin, one-sided 5% alpha, 90% power, 10% loss to follow-up. Intervention: 7 days (no further treatment); comparison: 14 days (7 days postrandomisation). Outcomes: Primary: relapse (definite or probable) within day 21 postantibiotic completion. Secondary outcomes: composite of mortality or definite/probable/secondary sepsis and duration of hospitalisation. One interim analysis (per protocol (PP)) was planned. Results: 126 and 135 subjects were recruited in 7-day and 14-day groups, respectively, with mean (SD) birth weight (BW) 2250.9 (741.1) and 2187.8 (718.8) g. The trial was terminated early, based on interim PP analysis. 2/125 and 6/130 subjects had the primary outcome in 7-day and 14-day groups, respectively (risk difference (RD)=−3.0% (99.5% CI −9.2%, +3.1%), below non-inferiority margin). The composite secondary outcome also favoured the 7-day regimen (RD: −3.7% (99.5% CI −12.4% to +5.1%)). Duration of hospitalisation was shorter in 7-day group (median difference: −4 days (95% CI −5 to –3)). Conclusions: A 7-day course of antibiotics may be non-inferior to a 14-day course for uncomplicated bacterial neonatal sepsis. Trial registration number: NCT03280147.
- 25 April 2025
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
Seven-day versus 14-day antibiotic course for culture-proven neonatal sepsis: a multicentre randomised non-inferiority trial in a low and middle-income country
Objective: Definitive guidance regarding the duration of antibiotics for neonatal sepsis is lacking. We hypothesised that a 7-day antibiotic course is non-inferior to a 14-day course for treating culture-proven sepsis. Design: Randomised, controlled, non-inferiority trial with masked outcome assessment in eight centres in a low and middle-income country. Patients: Neonates with a birth weight (BW) ≥1000 g and blood culture-proven sepsis were randomised on day 7 of sensitive antibiotic therapy provided sepsis had clinically remitted. Exclusions: Staphylococcus aureus or fungal sepsis, and infections requiring prolonged antibiotics. We planned to enrol 350 per group, assuming 10% rate of primary outcome, +7% non-inferiority margin, one-sided 5% alpha, 90% power, 10% loss to follow-up. Intervention: 7 days (no further treatment); comparison: 14 days (7 days postrandomisation). Outcomes: Primary: relapse (definite or probable) within day 21 postantibiotic completion. Secondary outcomes: composite of mortality or definite/probable/secondary sepsis and duration of hospitalisation. One interim analysis (per protocol (PP)) was planned. Results: 126 and 135 subjects were recruited in 7-day and 14-day groups, respectively, with mean (SD) birth weight (BW) 2250.9 (741.1) and 2187.8 (718.8) g. The trial was terminated early, based on interim PP analysis. 2/125 and 6/130 subjects had the primary outcome in 7-day and 14-day groups, respectively (risk difference (RD)=−3.0% (99.5% CI −9.2%, +3.1%), below non-inferiority margin). The composite secondary outcome also favoured the 7-day regimen (RD: −3.7% (99.5% CI −12.4% to +5.1%)). Duration of hospitalisation was shorter in 7-day group (median difference: −4 days (95% CI −5 to –3)). Conclusions: A 7-day course of antibiotics may be non-inferior to a 14-day course for uncomplicated bacterial neonatal sepsis. Trial registration number: NCT03280147.
- 10 April 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (4) , 312-314
Gestational Age Maturity: Have Our Assessment Tools Truly Matured and Come of Age?
- 10 April 2025
- Published by Springer Nature in Indian Pediatrics
- Vol. 62 (4) , 312-314
Gestational Age Maturity: Have Our Assessment Tools Truly Matured and Come of Age?
- Open Access
- 3 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (3) , 577
Gut Microbiota Alteration in Healthy Preterm Infants: An Observational Study from Tertiary Care Center in India
Various prenatal and postnatal factors such as gestational age, mode of delivery, sex, antibiotic exposure, feeding type, duration of feed and other exposures associated with the hospital environment can drive the formation of gut microbiota. In the current study, we examined the role of all these factors in the gut microbiota of healthy Indian preterm infants admitted to NICU in the first four weeks of life. Preterm neonates admitted to the NICU from April 2023 and October 2023 were recruited and fecal samples were collected weekly once beginning from the seventh day till the 30th day of life. 16s rRNA gene sequencing was performed on the NovaSeq 6000 platform. The PICRUSt2 tool was used to predict the functional profiles of the gut microbiome. A total of 61 samples were collected from 16 preterm infants. Alpha and beta diversity showed the administration of probiotics, postnatal age, mode of delivery, and sex of infants as major contributors to altered microbial diversity in preterm infants. The MaAsLin2 analysis showed that the supplementation of probiotics increased Bifidobacterium levels. PICRUSt2 analysis revealed that probiotic supplementation increased the bacterial genes responsible for bile acid metabolism and glycosphingolipid synthesis. Probiotics and postnatal age are responsible for alterations of the gut microbial composition in healthy preterm infants.
- 3 March 2025
- Published by MDPI AG in Microorganisms
- Vol. 13 (3) , 577
Open AccessGut Microbiota Alteration in Healthy Preterm Infants: An Observational Study from Tertiary Care Center in India
Various prenatal and postnatal factors such as gestational age, mode of delivery, sex, antibiotic exposure, feeding type, duration of feed and other exposures associated with the hospital environment can drive the formation of gut microbiota. In the current study, we examined the role of all these factors in the gut microbiota of healthy Indian preterm infants admitted to NICU in the first four weeks of life. Preterm neonates admitted to the NICU from April 2023 and October 2023 were recruited and fecal samples were collected weekly once beginning from the seventh day till the 30th day of life. 16s rRNA gene sequencing was performed on the NovaSeq 6000 platform. The PICRUSt2 tool was used to predict the functional profiles of the gut microbiome. A total of 61 samples were collected from 16 preterm infants. Alpha and beta diversity showed the administration of probiotics, postnatal age, mode of delivery, and sex of infants as major contributors to altered microbial diversity in preterm infants. The MaAsLin2 analysis showed that the supplementation of probiotics increased Bifidobacterium levels. PICRUSt2 analysis revealed that probiotic supplementation increased the bacterial genes responsible for bile acid metabolism and glycosphingolipid synthesis. Probiotics and postnatal age are responsible for alterations of the gut microbial composition in healthy preterm infants.
- 13 February 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (3) , 342-349
Early hydrocortisone verses placebo in neonatal shock- a double blind Randomized controlled trial
To compare early hydrocortisone (initiated along with vasoactive therapy) vs. placebo for all-cause mortality within next 14 days among neonates with fluid-refractory shock. Neonates with fluid-refractory shock were randomly assigned to receive hydrocortisone or saline placebo alongside vasoactive drugs. If they developed catecholamine-resistant shock, the study drug was replaced with open-label hydrocortisone. Eighty-four neonates were randomized (early hydrocortisone=43 and placebo=41). Median gestational age of our cohort (n = 84) was 30.3 weeks [interquartile range (IQR): 27.7, 32.5] and median birth weight was 1148 grams (IQR: 860, 1419). The 14-day all-cause mortality was comparable between early hydrocortisone and placebo groups [OR 0.53 (95% CI 0.19, 1.52)]. Both groups had similar duration of vasoactive drugs and vasoactive-inotrope scores, incidence of adverse effects of hydrocortisone and incidence of medium-term complications. We did not observe a significant reduction in 14-day mortality with early hydrocortisone compared to placebo in fluid-refractory neonatal shock.
- 13 February 2025
- Published by Springer Nature in Journal of Perinatology
- Vol. 45 (3) , 342-349
Early hydrocortisone verses placebo in neonatal shock- a double blind Randomized controlled trial
To compare early hydrocortisone (initiated along with vasoactive therapy) vs. placebo for all-cause mortality within next 14 days among neonates with fluid-refractory shock. Neonates with fluid-refractory shock were randomly assigned to receive hydrocortisone or saline placebo alongside vasoactive drugs. If they developed catecholamine-resistant shock, the study drug was replaced with open-label hydrocortisone. Eighty-four neonates were randomized (early hydrocortisone=43 and placebo=41). Median gestational age of our cohort (n = 84) was 30.3 weeks [interquartile range (IQR): 27.7, 32.5] and median birth weight was 1148 grams (IQR: 860, 1419). The 14-day all-cause mortality was comparable between early hydrocortisone and placebo groups [OR 0.53 (95% CI 0.19, 1.52)]. Both groups had similar duration of vasoactive drugs and vasoactive-inotrope scores, incidence of adverse effects of hydrocortisone and incidence of medium-term complications. We did not observe a significant reduction in 14-day mortality with early hydrocortisone compared to placebo in fluid-refractory neonatal shock.